Preterm Delivery clinical trials at UCSF

1 research study open to eligible people

Preterm delivery means having a baby earlier than 37 weeks. UCSF is conducting studies on using aspirin to prevent early births in women who have had them before. Researchers are trying to find the safest and most effective aspirin dose for future pregnancies.

Showing trials for

  • Aspirin Dose Escalation for the Prevention of Recurrent Preterm Delivery Trial

    open to eligible females ages 14 years and up

    This is a phase-III multi-center double-blind randomized clinical trial of 1,800 individuals with a history of prior preterm birth at less than 35 weeks gestation who are randomized to either 162 mg aspirin or 81 mg aspirin daily. The study drug will be initiated between 10 and 15 weeks gestation and continued through 36 weeks, 6 days gestation. The primary endpoint is recurrent preterm delivery or fetal death prior to 35 weeks, 0 days gestation.

    San Francisco, California and other locations

Last updated: